Fundraising Fox
Innoblative
Chicago, US · Founded 2013 · 3 known investors
Find your way into Innoblative
Sign up to see every warm intro you have to Innoblative
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Innoblative team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Innoblative Designs develops a medical device for breast-conserving therapy, focused on treating breast cancer during surgical procedures. The company operates in the medtech sector.
Founders & leadership
Innoblative was founded in 2013 by Tyler Wanke.
Investors · 3
Reported raises · per SEC filings
Form D private placements$9.4M disclosed across 3 rounds · 2014–2017
▶$7.2MraisedOct 2019 · 37 investors · OtherRule 506(b)
- Kelly LondyExecutive Officer, Director
- Tyler WankeDirector
- Dianne BlancoDirector
- Matthew SteinmetzDirector
- Gintaras VaisnysDirector
- Offering amount
- $7.2M
- Amount sold
- $7.2M
- Minimum investment
- $20K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedApr 2016 · 1 investors · OtherRule 506(b)
- Arthur HoldenDirector
- Matthew SteinmetzDirector
- Dianne BlancoDirector
- Gintaras VaisnysDirector
- Tyler WankeExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $25K
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$1.2MraisedJan 2016 · 21 investors · OtherRule 506(b)
- Tyler WankeExecutive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- Minimum investment
- $5K
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Innoblative.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase IISTTR | 2017 | $486.2K |
| National Science Foundation | Phase ISTTR | 2016 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Innoblative do?
- Innoblative Designs develops a medical device for breast-conserving therapy, focused on treating breast cancer during surgical procedures. The company operates in the medtech sector.
- Who founded Innoblative?
- Innoblative was founded by Tyler Wanke in 2013.
- Who are Innoblative's investors?
- Innoblative's investors include Alumni Ventures, Bascom Ventures, Boston Harbor Angels.
- How much funding has Innoblative raised?
- Innoblative has disclosed $9.4M raised across 3 rounds.
- Where is Innoblative headquartered?
- Innoblative is headquartered in Chicago, US.